[BMR] Biomed Realty Trust
Overview
Type of security: Stock
Sector: Consumer Services
Industry: Real Estate Investment Trusts
Market Capitalization: 4.81 B
Exchange: NYSE
The data is delayed by 15 minutes.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. Its tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies, and other entities involved in the life science industry. The company owns or has interests in 72 properties, representing 119 buildings with approximately 11.0 million rentable square feet. Its properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania, and New York/New Jersey. The company qualifies as a REIT for federal income tax purposes. It would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. BioMed Realty Trust was founded in 2004 and is based in San Diego, California.
See how to gain 20% in 14 sec with TrendsInvesting
Fundamental Ratios
| Shares Outstanding | 202.02 M | EPS | 0.65 | EPS Growth - 4 Quarters | 15.25% | EPS Growth - Q/Q | -207.05% |
| EPS Growth - Y/Y | -52.96% | Sales Growth - 4 Quarters | 4% | Sales Growth - Q/Q | 7.46% | P/E | 36.57 |
| P/E To EPS Growth | -4.93 | P/S | 7.02 | P/BV | 1.56 | Price/Cash Per Share | |
| Price/Free Cash Flow | -41.23 | ROA | 3.05% | ROE | 6.24% | ROI | |
| Current Ratio | Quick Ratio | Long Term Debt/Equity | Debt Ratio | ||||
| Gross Margin | 67.73% | Operating Margin | 19.98% | Net Profit Margin | 28.12% | Dividend Payout Ratio | -133.23% |
| Dividend Yield | -5.33% |
Fundamental Data
| Cash From Financing Activities | 158.42 M | Cash From Investing Activities | -292.32 M | Cash From Operating Activities | 132.15 M | Gross Profit | 102.7 M |
| Net Profit | 23.58 M | Operating Profit | -7.27 M | Total Assets | 6.34 B | Total Current Assets | |
| Total Current Liabilities | Total Debt | 2.9 B | Total Liabilities | 3.32 B | Total Revenue | 157.97 M |
Technical Data
| High 52 week | 24.05 | Low 52 week | 17.88 | Last close | 23.81 | Last change | 0.17% |
| RSI | 64.1 | Average true range | 0.06 | Beta | 1.36 | Volume | |
| Simple moving average 20 days | 0.38% | Simple moving average 50 days | 0.96% | Simple moving average 200 days | 11.86% |
Performance Data
| Performance Week | 0.38% | Performance Month | 0.8% | Performance Quart | 2.59% | Performance Half | 17.78% |
| Performance Year | -0.96% | Performance Year-to-date | 0.51% | Volatility daily | 0.13% | Volatility weekly | 0.28% |
| Volatility monthly | 0.58% | Volatility yearly | 2% | Relative Volume | 0% | Average Volume | 4.35 M |
| New High | New Low |
News
2018-09-21 12:15:32 | What Do Analysts Recommend for Sage in September?
2018-04-25 09:26:17 | Are Medard SA.’s WSE:BMR Interest Costs Too High?
2017-04-27 09:15:09 | Decade in the making, massive biotech project set to break ground in South S.F.
2017-01-12 10:10:08 | Builder of lab space acquires full block in South Lake Union
2017-01-04 03:43:06 | BRM undiluted NAV as at 31/12/16 - $0.6521
2016-12-19 09:00:00 | Harbour BioMed Acquires Harbour Antibodies to Create Global, Oncology-focused Biotechnology Company
2016-11-22 13:44:32 | BioMed Realty Secures New Anchor Tenant For Iconic 500 Kendall Street Building
2016-10-03 04:16:09 | BRM - Ongoing Disclosure Notice Alistair Ryan BRM - Ongoing Disclosure Notice Alistair Ryan
2016-10-03 04:16:09 | BRM - Ongoing Disclosure Notice Richard Andrew Coupe BRM - Ongoing Disclosure Notice Richard Andrew Coupe
2016-09-30 04:01:06 | BRM - Issue of Securities - 30 September 2016 BRM - Issue of Securities - 30 September 2016
2016-09-29 03:20:05 | BRM NAV as at 28/9/16 - $0.6885 BRM - NTA
2016-09-22 17:21:09 | BRM - Notice of Meeting of Shareholders - 28 October 2016 BRM - Notice of Meeting 2016
2016-09-22 17:11:03 | BRM - Notice of Meeting of Shareholders - 28 October 2016 BRM - Proxy Form 2016
2016-09-22 03:31:07 | BRM - 30 June 2016 Annual Report and Section 209 Notice BRM - 30 June 2016 Annual Report
2016-09-22 03:31:07 | BRM NAV as at 21/9/16 - $0.6676 BRM - NTA
2016-09-15 03:58:05 | BRM ex-div NAV as at 14/9/16 - $0.6543 BRM - ex-div NTA
2016-09-08 03:29:06 | BRM NAV as at 7/9/16 - $0.6895
2016-09-02 03:35:08 | BRM - Ongoing Disclosure Notice Carol Campbell BRM - Ongoing Disclosure Notice Carol Campbell
2016-09-02 03:35:08 | BRM - Ongoing Disclosure Notice Alistair Ryan BRM - Ongoing Disclosure Notice Alistair Ryan
2016-09-02 03:35:08 | BRM - Ongoing Disclosure Notice Richard Andrew Coupe BRM - Ongoing Disclosure Notice Richard Andrew Coupe
2016-09-01 04:03:04 | BRM NAV as at 31/8/16 - $0.7012 BRM - NTA
2016-09-01 04:03:04 | Annual Meeting and Closing Date for Nomination of Directors BRM - Annual Meeting and Closing Date for Nomination of Directors
2016-08-26 03:58:05 | BRM - Notice of acquisition of securities 25 August 2016 BRM - Notice of acquisition of securities
2016-08-25 03:48:08 | BRM NAV as at 24/8/16 - $0.7113 BRM - NTA
2016-08-25 03:48:08 | BRM - Notice of acquisition of securities 24 August 2016 BRM - Notice of acquisition of securities
2016-08-22 03:38:06 | BRM - Quarterly dividend of 1.40 cents per share BRM - Appendix 7
2016-08-22 03:38:05 | Barramundi renews Management Agreement with Fisher Funds Barramundi renews Management Agreement with Fisher Funds
2016-01-28 16:20:14 | BioMed Realty, L.P. -- Moody's downgrades BioMed Realty to Ba1; outlook negative
2016-01-27 16:07:29 | BIOMED REALTY TRUST INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition
2016-01-27 14:47:00 | Blackstone Completes Acquisition Of BioMed Realty Trust
2016-01-25 16:01:00 | BioMed Realty Trust Announcement Relating To Completion Of Acquisition By Blackstone
2016-01-22 17:48:00 | Federal Realty Investment Trust Set to Join the S&P 500; Curtiss-Wright, Pool to Join S&P MidCap 400; Cray, Asbury Automotive to Join S&P SmallCap 600
2016-01-22 14:05:00 | BioMed Realty Trust Announces Tax Treatment Of 2015 Distributions
2016-01-21 17:01:52 | BIOMED REALTY TRUST INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financ
2016-01-21 16:01:00 | BioMed Realty Trust Stockholders Approve Acquisition By Blackstone
2016-01-06 17:12:08 | BioMed Settles Lawsuits to Move Ahead With Buyout by Blackstone
2016-01-06 16:31:31 | BIOMED REALTY TRUST INC Files SEC form 8-K, Other Events
2016-01-04 16:33:39 | BIOMED REALTY TRUST INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
2015-12-08 13:17:11 | BIOMED REALTY TRUST INC Financials
2015-11-30 13:59:12 | What Does The Smart Money Think of Biomed Realty Trust Inc BMR?
2015-11-26 14:23:47 | Do Hedge Funds Love United Microelectronics Corp ADR UMC?
2015-11-20 18:46:06 | Hedge Funds Abandoning Juno Therapeutics Inc JUNO In Droves
2015-11-17 10:27:25 | BioMed Realty Trust, Inc. Earnings Q3, 2015
2015-11-05 18:17:51 | BioMed reports 3Q results
2015-11-05 16:29:33 | BIOMED REALTY TRUST INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial St
2015-10-08 07:57:52 | Blackstone to buy BioMed Realty in $8 bln deal
2015-10-08 06:50:18 | BioMed selling to Blackstone for $8 billion
2015-10-08 06:10:23 | Blackstone Real Estate to buy BioMed Realty for $8 bln
2015-09-23 12:06:14 | What Hedge Funds Think Of These Two Stocks On A Roll Today
2015-09-22 20:11:09 | BioMed Realty Trust in talks to sell itself - Bloomberg